261
Views
4
CrossRef citations to date
0
Altmetric
MIDDLE EAR

Increased expression of Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA in chronic otitis media with cholesteatoma

, , , , , , & show all
Pages 475-480 | Received 08 Nov 2013, Accepted 08 Dec 2013, Published online: 07 Apr 2014

References

  • Louw L. Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol 2013;127:542–9.
  • Jung TT, Alper CM, Hellstrom SO, Hunter LL, Casselbrant ML, Groth A, et al. Panel 8: Complications and sequelae. Otolaryngol Head Neck Surg 2013;148:E122–43.
  • Welkoborsky HJ. Current concepts of the pathogenesis of acquired middle ear cholesteatoma. Laryngorhinootologie 2011;90:38–48.
  • Bernstein JM. New perspectives on immunologic reactivity in otitis media with effusion. Ann Otol Rhinol Laryngol 1988;97:19–23.
  • Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54:1–13.
  • Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009;21:317–37.
  • Hardison SE, Brown GD. C-type lectin receptors orchestrate antifungal immunity. Nat Immunol 2012;13:817–22.
  • Kim MG, Park DC, Shim JS, Jung H, Park MS, Kim YI, et al. TLR-9, NOD-1, NOD-2, RIG-I and immunoglobulins in recurrent otitis media with effusion. Int J Pediatr Otorhinolaryngol 2010;74:1425–9.
  • Lee HY, Chung JH, Lee SK, Byun JY, Kim YI, Yeo SG. Toll-like receptors, cytokines and nitric oxide synthase in patients with otitis media with effusion. Indian J Med Res 2013;138:523–30.
  • Kim YJ, Cha SH, Lee HY, Lee SK, Jung HH, Yeo JH, et al. Decreased pattern-recognition receptor-mediated cytokine mRNA expression in obese children with otitis media with effusion. Clin Exp Otorhinolaryngol 2014;7:1–6.
  • Palva T. Surgical treatment of chronic middle ear disease III. Revisions after tympanomastoid surgery. Acta Otolaryngol 1988;105:82–9.
  • Smyth GDL. Chronic ear disease. New York: Churchill Livingstone. 1980.
  • Lee HY, Park MS, Byun JY, Kim YI, Yeo SG. Expression of pattern recognition receptors in cholesteatoma. Eur Arch Otorhinolaryngol 2014;271:245–53.
  • Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 2009;9:465–79.
  • Dong W, Liu Y, Peng J, Chen L, Zou T, Xiao H, et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4. J Biol Chem 2006;281:26029–40.
  • Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJ, Njoku DB, et al. Tim-3, Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006;176:6411–15.
  • Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;164:4991–5.
  • Ricciardiello F, Cavaliere M, Mesolella M, Iengo M. Notes on the microbiology of cholesteatoma: clinical findings and treatment. Acta Otorhinolaryngol Ital 2009;29:197–202.
  • Martins O, Victor J, Selesnick S. The relationship between individual ossicular status and conductive hearing loss in cholesteatoma. Otol Neurotol 2012;33:387–92.
  • Masuda M, Kanzaki S, Minami S, Kikuchi J, Kanzaki J, Sato H, et al. Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2012;33:1142–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.